{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T04:35:44Z","timestamp":1781930144892,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T00:00:00Z","timestamp":1487721600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s40262-017-0515-7","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T05:50:39Z","timestamp":1487742639000},"page":"1231-1244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach"],"prefix":"10.1007","volume":"56","author":[{"given":"Laureen A.","family":"Lammers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roos","family":"Achterbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron H. N.","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Romijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron A. A.","family":"Math\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,22]]},"reference":[{"issue":"2","key":"515_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/138920007779816002","volume":"8","author":"JH Lin","year":"2007","unstructured":"Lin JH. Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy. Curr Drug Metab. 2007;8(2):109\u201336.","journal-title":"Curr Drug Metab"},{"issue":"1","key":"515_CR2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103\u201341.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"515_CR3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2796.2001.00879.x","volume":"250","author":"M Ingelman-Sundberg","year":"2001","unstructured":"Ingelman-Sundberg M. Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy. J Intern Med. 2001;250(3):186\u2013200.","journal-title":"J Intern Med"},{"issue":"1","key":"515_CR4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2174\/138920006774832569","volume":"7","author":"M Murray","year":"2006","unstructured":"Murray M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr Drug Metab. 2006;7(1):67\u201381.","journal-title":"Curr Drug Metab"},{"issue":"3","key":"515_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/03602532.2011.577781","volume":"43","author":"MD Merrell","year":"2011","unstructured":"Merrell MD, Cherrington NJ. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metab Rev. 2011;43(3):317\u201334.","journal-title":"Drug Metab Rev"},{"issue":"11","key":"515_CR6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0006-2952(00)00266-5","volume":"59","author":"V Longo","year":"2000","unstructured":"Longo V, Ingelman-Sundberg M, Amato G, Salvetti A, Gervasi PG. Effect of starvation and chlormethiazole on cytochrome P450s of rat nasal mucosa. Biochem Pharmacol. 2000;59(11):1425\u201332.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"515_CR7","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/mol.54.3.504","volume":"54","author":"W Qu","year":"1998","unstructured":"Qu W, Rippe RA, Ma J, Scarborough P, Biagini C, Fiedorek FT, et al. Nutritional status modulates rat liver cytochrome P450 arachidonic acid metabolism. Mol Pharmacol. 1998;54(3):504\u201313.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"515_CR8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1124\/dmd.114.062299","volume":"43","author":"LA Lammers","year":"2015","unstructured":"Lammers LA, Achterbergh R, de Vries EM, van Nierop FS, Klumpen HJ, Soeters MR, et al. Short-term fasting alters cytochrome P450-mediated drug metabolism in humans. Drug Metab Dispos. 2015;43(6):819\u201328.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"515_CR9","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1365-2125.2009.03548.x","volume":"68","author":"S Turpault","year":"2009","unstructured":"Turpault S, Brian W, Van Horn R, Santoni A, Poitiers F, Donazzolo Y, et al. Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol. 2009;68(6):928\u201335.","journal-title":"Br J Clin Pharmacol"},{"key":"515_CR10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pharmtox.43.100901.140251","volume":"43","author":"X Ding","year":"2003","unstructured":"Ding X, Kaminsky LS. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol. 2003;43:149\u201373.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5","key":"515_CR11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0009-9236(96)90177-0","volume":"59","author":"KE Thummel","year":"1996","unstructured":"Thummel KE, O\u2019Shea D, Paine MF, Shen DD, Kunze KL, Perkins JD, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther. 1996;59(5):491\u2013502.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"515_CR12","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/clinchem\/24.9.1568","volume":"24","author":"KJ Foster","year":"1978","unstructured":"Foster KJ, Alberti KG, Hinks L, Lloyd B, Postle A, Smythe P, et al. Blood intermediary metabolite and insulin concentrations after an overnight fast: reference ranges for adults, and interrelations. Clin Chem. 1978;24(9):1568\u201372.","journal-title":"Clin Chem"},{"key":"515_CR13","volume-title":"Micromedex solutions\u2014drug monographs","author":"Micromedex","year":"2014","unstructured":"Micromedex. Micromedex solutions\u2014drug monographs. 2014th ed. Greenwood Village: Truven Health Analytics Inc; 2014.","edition":"2014"},{"issue":"6","key":"515_CR14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/FTD.0000000000000338","volume":"38","author":"LA Lammers","year":"2016","unstructured":"Lammers LA, Achterbergh R, Pistorius MC, Bijleveld Y, de Vries EM, Boelen A, et al. Quantitative method for simultaneous analysis of a 5-probe cocktail for cytochrome P450 enzymes. Ther Drug Monit. 2016;38(6):761\u20138.","journal-title":"Ther Drug Monit"},{"key":"515_CR15","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1038\/psp.2013.14","volume":"2","author":"DR Mould","year":"2013","unstructured":"Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development-part 2: introduction to pharmacokinetic modeling methods. CPT Pharmacomet Syst Pharmacol. 2013;2:e38.","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"5","key":"515_CR16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10928-007-9066-0","volume":"34","author":"RM Savic","year":"2007","unstructured":"Savic RM, Jonker DM, Kerbusch T, Karlsson MO. Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 2007;34(5):711\u201326.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"515_CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO. Xpose: an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999;58(1):51\u201364.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"515_CR18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cmpb.2010.04.018","volume":"101","author":"RJ Keizer","year":"2011","unstructured":"Keizer RJ, van Benten M, Beijnen JH, Schellens JH, Huitema AD. Pirana and PCluster: a modeling environment and cluster infrastructure for NONMEM. Comput Methods Programs Biomed. 2011;101(1):72\u20139.","journal-title":"Comput Methods Programs Biomed"},{"issue":"1","key":"515_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","volume":"82","author":"MO Karlsson","year":"2007","unstructured":"Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther. 2007;82(1):17\u201320.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"515_CR20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/bcp.12883","volume":"81","author":"YA Bijleveld","year":"2016","unstructured":"Bijleveld YA, de Haan TR, van der Lee HJ, Groenendaal F, Dijk PH, van Heijst A, et al. Altered gentamicin pharmacokinetics in term neonates undergoing controlled hypothermia. Br J Clin Pharmacol. 2016;81(6):1067\u201377.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"515_CR21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01061469","volume":"20","author":"JW Mandema","year":"1992","unstructured":"Mandema JW, Verotta D, Sheiner LB. Building population pharmacokinetic\u2013pharmacodynamic models. I. Models for covariate effects. J Pharmacokinet Biopharm. 1992;20(5):511\u201328.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"6","key":"515_CR22","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","volume":"37","author":"EI Ette","year":"1997","unstructured":"Ette EI. Stability and performance of a population pharmacokinetic model. J Clin Pharmacol. 1997;37(6):486\u201395.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"515_CR23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143\u201351.","journal-title":"AAPS J"},{"issue":"3","key":"515_CR24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","volume":"79","author":"L Lindbom","year":"2005","unstructured":"Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit: a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79(3):241\u201357.","journal-title":"Comput Methods Programs Biomed"},{"key":"515_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1472-6947-11-31","volume":"11","author":"X Sun","year":"2011","unstructured":"Sun X, Li J. PKreport: report generation for checking population pharmacokinetic model assumptions. BMC Med Inform Decis Mak. 2011;11:31.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"515_CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1067\/mcp.2002.121829","volume":"71","author":"LZ Benet","year":"2002","unstructured":"Benet LZ, Hoener BA. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002;71(3):115\u201321.","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"515_CR27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","volume":"64","author":"RK Verbeeck","year":"2008","unstructured":"Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64(12):1147\u201361.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"515_CR28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1079\/BJN19830057","volume":"49","author":"MA Lomax","year":"1983","unstructured":"Lomax MA, Baird GD. Blood flow and nutrient exchange across the liver and gut of the dairy cow. Effects of lactation and fasting. Br J Nutr. 1983;49(3):481\u201396.","journal-title":"Br J Nutr"},{"issue":"48","key":"515_CR29","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3748\/wjg.v16.i48.6046","volume":"16","author":"C Eipel","year":"2010","unstructured":"Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16(48):6046\u201357.","journal-title":"World J Gastroenterol"},{"issue":"24","key":"515_CR30","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.0708100105","volume":"105","author":"L Raffaghello","year":"2008","unstructured":"Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA. 2008;105(24):8215\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"515_CR31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s12885-015-1663-5","volume":"15","author":"S Groot de","year":"2015","unstructured":"de Groot S, Vreeswijk MP, Welters MJ, Gravesteijn G, Boei JJ, Jochems A, et al. The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. 2015;15:652.","journal-title":"BMC Cancer"},{"issue":"14","key":"515_CR32","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/15384101.2015.1044170","volume":"14","author":"SA Huisman","year":"2015","unstructured":"Huisman SA, Bijman-Lagcher W, Ijzermans JN, Smits R, de Bruin RW. Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice. Cell Cycle. 2015;14(14):2333\u20139.","journal-title":"Cell Cycle"},{"issue":"1","key":"515_CR33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cmet.2015.05.012","volume":"22","author":"S Brandhorst","year":"2015","unstructured":"Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab. 2015;22(1):86\u201399.","journal-title":"Cell Metab"},{"issue":"11","key":"515_CR34","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/sj.onc.1209377","volume":"25","author":"C Rodriguez-Antona","year":"2006","unstructured":"Rodriguez-Antona C, Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene. 2006;25(11):1679\u201391.","journal-title":"Oncogene"},{"issue":"2","key":"515_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/187569209788654005","volume":"7","author":"JP Hernandez","year":"2009","unstructured":"Hernandez JP, Mota LC, Baldwin WS. Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation. Curr Pharmacogenom Pers Med. 2009;7(2):81\u2013105.","journal-title":"Curr Pharmacogenom Pers Med"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-017-0515-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0515-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0515-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T20:52:50Z","timestamp":1601671970000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-017-0515-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,22]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s40262-017-0515-7","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,22]]}}}